SEARCH

SEARCH BY CITATION

References

  • 1
    Gerritsen EJ,Vossen JM,van Loo IH, et al. Autosomal recessive osteopetrosis: Variability of findings at diagnosis and during the natural course. Pediatrics 1994; 93: 247253.
  • 2
    Fasth A,Porras O. Human malignant osteopetrosis: Pathophysiology, management and the role of bone marrow transplantation. Pediatr Transplant 1999; 3( Suppl 1): 102107.
  • 3
    Wilson CJ,Vellodi A. Autosomal recessive osteopetrosis: Diagnosis, management and outcome. Arch Dis Child 2000; 83: 449452.
  • 4
    Mohn A,Capanna R,Delli Pizzi C, et al. Autosomal malignant osteopetrosis. Minerva Pediatr 2004; 56: 115118.
  • 5
    Steward CG. Neurological aspects of osteopetrosis. Neuropathol Appl Neurobiol 2003; 29: 8797.
  • 6
    Walker DG. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science 1975; 190: 784785.
  • 7
    Walker DG. Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through use of bone marrow and splenic transplants. J Exp Med 1975; 142: 651663.
  • 8
    Ballet JJ,Griscelli C,Coutris C, et al. Bone marrow transplantation in osteopetrosis. Lancet 1977; 2: 1137.
  • 9
    Coccia PF,Krivit W,Cervenka J, et al. Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 1980; 302: 701708.
  • 10
    Fischer A,Griscelli C,Friedrich W, et al. Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968–1985. Lancet 1986; 2: 10801084.
  • 11
    Gerritsen EJ,Vossen JM,Fasth A, et al. Bone marrow transplantation for autosomal recessive osteopetrosis. J Pediatr 1994; 125: 896902.
  • 12
    Driessen GJA,Gerritsen EJ,Fischer A, et al. Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: An EBMT report. Bone Marrow Transplant 2003; 32: 657663.
  • 13
    Key LL,Carnes D,Cole S, et al. Treatment of congenital osteopetrosis with high-dose calcitriol. N Engl J Med 1984; 310: 409415.
  • 14
    Key LLJr,Rodriguiz RM,Willi SM, et al. Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med 1995; 332: 15941599.
  • 15
    Sobacchi C,Frattini A,Orchard P, et al. The mutational spectrum of human malignant autosomal recessive asteopetrosis. Hum Mol Genet 2001; 10: 17671773.
  • 16
    Guerrini MM,Sobacchi C,Cassani B, et al. Human osteoclast poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet 2008; 83: 6476.
  • 17
    Frattini A,Pangrazio A,Susani L, et al. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant and intermediate osteopetrosis. J Bone Miner Res 2003; 18: 17401747.
  • 18
    Chalhoub N,Benachenhou N,Rajapurohitam V, et al. Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat Med 2003; 9: 399406.
  • 19
    Ramirez A,Faupel J,Goebel I, et al. Identification of a novel mutation in the coding region of the grey-lethal gene OSTM1 in human malignant infantile osteopetrosis. Hum Mut 2004; 23: 471476.
  • 20
    Frattini A,Orchard PJ,Sobacchi C, et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 2000; 25: 343346.
  • 21
    Kornak U,Kasper D,Bösl MR, et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001; 104: 205215.
  • 22
    Quarello P,Forni M,Barberis L, et al. Severe malignant osteopetrosis caused by a GL gene mutation. J Bone Miner Res 2004; 19: 11941199.
  • 23
    Sobacchi C,Frattini A,Guerrini MM, et al. Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet 2007; 39: 960962.
  • 24
    Kaplan EL,Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457481.
  • 25
    Van Wesenbeeck L,Van Hul W. Lessons from osteopetrotic mutations in animals: Impact on our current understanding of osteoclast biology. Crit Rev Eukaryot Gene Expr 2005; 15: 133162.
  • 26
    Segovia-Silvestre T,Neutzsky-Wulff AV,Sorensen MG, et al. Advances in osteoclast biology resulting from the study of osteopetrotic mutations. Hum Genet 2009; 124: 561577.
  • 27
    Tolar J,Teitelbaum SL,Orchard PJ. Mechanisms of disease. Osteopetrosis. N Engl J Med 2004; 351: 28392849.
  • 28
    Balemans W,Van Wesenbeeck L,Van Hul W. A clinical and molecular overview of the human osteopetrosis. Calcif Tissue Int 2005; 77: 263274.
  • 29
    Askmyr MK,Fasth A,Richter J. Towards a better understanding and new therapeutics of osteopetrosis. Br J Haematol 2008; 140: 597609.
  • 30
    Pangrazio A,Poliani PL,Megarbane A, et al. Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement. J Bone Miner Res 2006; 21: 10981105.
  • 31
    Maranda B,Chabot G,Décarie JC, et al. Clinical and cellular manifestations of OSTM1-related infantile osteopetrosis. J Bone Miner Res 2008; 23: 296300.
  • 32
    Castellano Chiodo D,DiRocco M,Gandolfo C, et al. Neuroimaging findings in malignant infantile osteopetrosis due to OSTM1 mutations. Neuropediatrics 2007; 38: 154156.
  • 33
    Kasper D,Planells-Cases R,Fuhrmann JC, et al. Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J 2005; 24: 10791091.
  • 34
    Jentsch TJ. Chloride and the endosomal-lysosomal pathway: Emerging roles of ClC chloride transporters. J Physiol 2007; 578: 633640.
  • 35
    Lange PF,Wartosch L,Jentsch TJ,Fuhrmann JC. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 2006; 440: 220223.
  • 36
    Feigin ME,Malbon CC. OSTM1 regulates beta-catenin/Lef1 interaction and is required for Wnt/beta-catenin signaling. Cell Signal 2008; 20: 949957.
  • 37
    Prinetti A,Rocchetta F,Costantino E, et al. 2008. Brain lipid composition in grey-lethal mutant mouse characterized by severe malignant osteopetrosis. Glycoconj J.10.1007/s10719-008-9179-8.
  • 38
    Steward CG,Pellier I,Mahajan A, et al. Severe pulmonary hypertension: A frequent complication of stem cell transplantation for malignant infantile osteopetrosis. J Haematol 2004; 124: 6371.
  • 39
    Kasow KA,Bonfim C,Asch J, et al. Malignant infantile osteopetrosis and primary pulmonary hypertension: A new combination? Pediatr Blood Cancer 2004; 42: 190194.
  • 40
    Simonet WS,Lacey DL,Dunstan, et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309319.
  • 41
    Yoshida H,Hayashi S,Kunisada T, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990; 345: 442444.
  • 42
    Lawrie A,Waterman E,Southwood M, et al. Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension. Am J Pathol 2008; 172: 256264.
  • 43
    Blin-Wakkach C,Wakkach A,Sexton PM, et al. Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis. Leukemia 2004; 18: 15051511.
  • 44
    Utku N,Heinemann T,Tullius SG, et al. Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein. Immunity 1998; 9: 509518.
  • 45
    Heinemann T,Bulwin GC,Randall J, et al. Genomic organization of the gene coding for TIRC7, a novel membrane protein essential for T cell activation. Genomics 1999; 57: 398406.
  • 46
    Utku N,Boerner A,Tomschegg A. TIRC7 deficiency causes in vitro and in vivo augmentation of T and B cell activation and cytokine response. JImmunol 2004; 173: 23422352.
  • 47
    Blin-Wakkach C,Wakkach A,Sexton PM, et al. Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis. Leukemia 2004; 18: 15051511.
  • 48
    Johansson M,Jansson L,Ehinger M, et al. Neonatal hematopoietic stem cell transplantation cures oc/oc mice from osteopetrosis. Exp Hematol 2006; 34: 242249.
  • 49
    Rossi SW,Kim MY,Leibbrandt A, et al. RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J Exp Med 2007; 204: 12671272.
  • 50
    Sun-Wada GH,Toyomura T,Murata Y, et al. The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. J Cell Sci 2006; 119: 45314540.
  • 51
    Sun-Wada GH,Tabata H,Kawamura N, et al. Differential expression of a subunit isoforms of the vacuolar-type proton pump ATPase in mouse endocrine tissues. Cell Tissue Res 2007; 329: 239248.
  • 52
    Corbacioglu S,Honig M,Stohr S, et al. Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide. Bone Marrow Transplant 2006; 38: 547553.
  • 53
    Frattini A,Blair HC,Sacco MG, et al. Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero. Proc Natl Acad Sci USA 2005; 102: 1462914634.
  • 54
    Tondelli B,Blair HC,Guerrini M, et al. Fetal liver cells transplanted in utero rescue the osteopetrotic phenotype in the oc/oc mouse. Am J Pathol 2009; 174: 727735.
  • 55
    Johansson MK,de Vries TJ,Schoenmaker T, et al. Hematopoietic stem cell targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice. Blood 2007; 15: 51785185.